Skip to main content

Table 2 Participant characteristics

From: Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations

 

Total (n = 36)

Sex

 Male

26 (72%)

 Female

10 (28%)

Age (years)

 Mean (range)

45 (24–63)

Ethnicity

 White/White British

24 (67%)

 Black/Black British

5 (14%)

 Asian/Asian British

1 (3%)

 Mixed or multiple

3 (8%)

 Other

3 (8%)

Current prescribed medication

 Daily oral methadone

12 (33%)

 Daily oral buprenorphine

12 (33%)

 Daily heroin (not in treatment)

12 (33%)

Frequency of medication collection from a pharmacy

 Daily

16 (44%)

 2–3 times a week

5 (14%)

 Weekly

3 (8%)

 Not applicable

12 (33%)

Current heroin use

 Yes

21 (58%)

 No

15 (42%)